How Do You Know When Semaglutide GLP-1 Is Working
Understanding these mechanisms can help you manage any side effects you experience and know when to seek medical advice
Rakipovski G, Rolin B, Nhr J, Klewe I, Frederiksen KS, Augustin R, et al
Longer term, it's the right thing to do." While Ozempic and Wegovy are known for inducing weight loss, Doustdar highlighted the drugs broader benefits for cardiovascular, kidney and liver health, most notably their ability to cure scarring in patients with fatty liver disease
Karl Nadolsky, an obesity-medicine specialist and AACE member, has stated: "Restricting access to GLP-1 receptor agonists through excessive step therapy contradicts the evidence base and delays treatment for a disease with cumulative cardiometabolic harm." The disconnect between this evidence and Kaiser's access barriers represents one of the more visible friction points in obesity pharmacotherapy coverage